Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.21668 | 68 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.03365 | 67 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.05282 | 67 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.88632 | 65 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.98518 | 66 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.37048 | 70 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.46601 | 71 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.07881 | 67 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.06272 | 67 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.00486 | 66 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.09351 | 67 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.04018 | 67 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.15443 | 68 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.13457 | 68 |